
RARE Market Cap & Key Metrics
Ultragenyx Pharmaceutical Inc.
$17.73
+$1.03(+6.17%)
45
Overall
40
Value
45
Tech
50
Quality
Market Cap
$1.81B
Volume
5.16M
52W Range
$12.73 - $39.89
Target Price
$25.05
RARE market cap is $1.81B. This page lists Ultragenyx Pharmaceutical Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
RARE Key Metrics
- Market cap
- $1.81B
- EPS estimate, current year
- $-3.21
- EPS growth, 3-year
- +0.00%
- Value score
- 40
- Quality score
- 50
- Technical score
- 45
| Fiscal year | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|
| Revenue | $51.49M | $2.61M | $133.0K | - | - |
| EBITDA | -$180.20M | -$310.81M | -$237.57M | -$138.60M | -$55.52M |
| EPS | $-1.73 | - | - | - | - |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RARE | $17.73 | +6.2% | 5.16M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Ultragenyx Pharmaceutical Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW